Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39641

DPCD Knockout huh-7 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Hepatocellular carcinoma

The DPCD Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting DPCD/CCDC151, a key factor in outer dynein arm assembly, within the Huh-7 hepatocyte-derived cell line. This loss-of-function model enables dissection of ciliary motility mechanisms and ciliopathy pathogenesis. DPCD acts downstream of FOXJ1/RFX3 and interacts with DNAH5, DNAI1, and CCDC114. The Huh-7 background supports ciliogenesis induction and is suitable for high-speed video microscopy, immunofluorescence, and drug screening in primary ciliary dyskinesia and male infertility studies, offering a tractable model for therapeutic development.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Huh-7

    Sex of Donor

    Male

    Age

    57 years

    Gene Name

    DPCD

    Gene Identifier

    NCBI Gene ID 25911

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DPCD Knockout Huh-7 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting DPCD (CCDC151) in human Huh-7 cells. This polyclonal format provides a genetically diverse loss-of-function model suitable for functional screening and pathway analysis without clonal selection artifacts. The pool is generated via CRISPR/Cas9-mediated gene disruption, ensuring efficient knockout across a heterogeneous population.

Derived from hepatocellular carcinoma, Huh-7 cells are an established hepatocyte-derived epithelial line widely used in liver cancer research and drug metabolism studies. They offer robust transfection efficiency and can be induced to undergo ciliogenesis under specialized culture conditions, making them a practical host for studying motile cilia biology despite their hepatic origin.

DPCD/CCDC151 encodes a scaffold protein critical for outer dynein arm assembly in motile cilia. It functions downstream of transcription factors FOXJ1, RFX3, and RFX2, and interacts with CCDC114, DNAH5, and DNAI1 to anchor dynein motors onto axonemal microtubules. This facilitates incorporation of DNAH5, DNAI1, and DNALI1, enabling ATP-dependent ciliary beating. Loss of DPCD disrupts dynein arm formation, leading to immotile cilia and associated phenotypes such as impaired mucociliary clearance and organ laterality defects.

In Huh-7 cells, DPCD knockout permits examination of dynein arm biogenesis and protein interactions in a metabolically active hepatic context. The cell line??s expression of key axonemal components and capacity for cilia formation upon induction provides a scalable platform for high-resolution imaging and biochemical studies. This model also facilitates compound screening for ciliary targets alongside hepatotoxicity assessment, leveraging Huh-7’s widespread use in drug metabolism assays.

Typical applications include immunofluorescence microscopy for dynein arm localization, co-immunoprecipitation and western blotting for interaction mapping, and high-speed video microscopy for ciliary beat frequency analysis after ciliogenesis induction. Air-liquid interface culture enables respiratory ciliary disease modeling and drug screening for primary ciliary dyskinesia therapies. This knockout system is also adaptable to sperm motility assays. For further information or custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)